Journals / European Journal of Therapeutics / 2020 / Cilt: 26 - Sayı: 2

Investigation of Various Virulence Factors and SCCmec Types in the Healthcare-associated and Community-associated Methicillin Resistance Staphylococcus aureus Strains

Pages
113–118
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: It is of clinical and epidemiological importance to know the origin of MRSA strains because this affects the empirical treatment choice.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The objective of this study was to investigate some virulence genes and SCCmec types of methicillin-resistant Staphylococcus aureus (MRSA) isolates and to determine their relationship with virulence factors.
📊
Key Findings & Data:Methods: A total of 100 MRSA strains, 64 from healthcare-associated and 36 from community-associated infections, were included in the study.
💡
Conclusion & Impact:Conclusions: It is of clinical and epidemiological importance to know the origin of MRSA strains because this affects the empirical treatment choice.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The objective of this study was to investigate some virulence genes and SCCmec types of methicillin-resistant Staphylococcus aureus (MRSA) isolates and to determine their relationship with virulence factors. Methods: A total of 100 MRSA strains, 64 from healthcare-associated and 36 from community-associated infections, were included in the study. The presence of mecA gene was investigated by PCR. SCCmec types and efb, clfB, agrA gene were detected by multiplex PCR and their relationship with virulence factors has been analyzed. Results: All of the isolates contain the mecA gene. At the same time, in 66 strains (66%) agrA gene, in 58 strains (58%) clfB gene, and in 47 strains (47%) efb gene were positive. In terms of SCCmec types, the distribution of these types among the 64 HA-SA strains was 53% similar-to-type-III, 16% type IV, 2% type I and 30% unclassified. The distribution of the types among the 36 CA-SA strains was 19% similar-to-type-III, 25% type IV, 8% type I and 47% unclassified, respectively. When SCCmec types were evaluated according to clinical sample type, similar-to-type-III isolates were found to be dominant in wound samples. Efb (78%), clfB (85%), agrA (88%) were the dominant genes in similar-to-type-III strains, whereas clfB (74%), agrA (100%) were the main genes detected in the type IV strains. Conclusions: It is of clinical and epidemiological importance to know the origin of MRSA strains because this affects the empirical treatment choice.

🔖

Cite This Article

KAYA, S., ERMERTCAN, Ş., ÖZTÜRK, İ., NEMLİ, S. A., YURTSEVER, S. G., AYGÜL, A. (2022). Investigation of Various Virulence Factors and SCCmec Types in the Healthcare-associated and Community-associated Methicillin Resistance Staphylococcus aureus Strains. European Journal of Therapeutics, Cilt: 26 - Sayı: 2, 113–118. https://ajindex.com/articles/512172

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Purrello SM, Daumb RS, Edwards GFS, Lina G, Lindsay J, Peters G, et al. Meticillin-resistant Staphylococcus aureus (MRSA) update: New insights into bacterial adaptation and therapeutic targets. J Global Antimicrob Resist. 2014; 2(2): 61–69.
  2. Santosaningsih D, Santoso S, Setijowati N, Rasyid HA, Budayanti NS, Suata K, et al. Prevalence and characterisation of Staphylococcus aureus causing community-acquired skin and soft tissue infections on Java and Bali, Indonesia. Trop Med Int Health. 2018;23(1):34-44.
  3. Lakhundi S, Zhang K. Methicillin-resistant Staphylococcus aureus: Molecular characterization, evolution, and epidemiology. Clin Microbiol Rev. 2018; 12; 31(4). pii: e00020-18. doi: 10.1128/CMR.0002018. Print 2018
  4. Oct. Fossum Moen AE, Saltyte Benth J, Alm-Kristiansen K, Bukholm G. Exotoxin-encoding gene content in community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect. 2009; 15(12): 1139–1145.
  5. Akoğlu H, Zarakolu P, Altun B, Ünal S. Epidemiological and molecular features of healthcare-associated methicillin-resistant Staphylococcus aureus strains isolated in Hacettepe University adult hospital in 2004-2005. Microbial Bul. 2010; 44: 343-355.
  6. Fasihi Y, Kiaei S, Kalantar-Neyestanaki D. Characterization of SCCmec and spa types of methicillin-resistant Staphylococcus aureus isolate from health-care and community-associated infections in Kerman, Iran. J Epidemiol Global Health. 2017; 7(4); 263-267.
  7. Saleem AJ, Nasser NE, Ali MR. Prevalence of genes encodİng enterotoxıns and exfoliative toxins among methicillin resistant Staphylococcus aureus clinical isolates in Iraq. World Journal of Pharmaceutical Research. 2016; 5(7): 208-216.
  8. Kong EF, Johnson JK, Jabra-Rizk MA. Community-associated methicillin-resistant Staphylococcus aureus: An Enemy amidst Us. PLoS Pathog. 2016;12(10): e1005837. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC Definitions for Nosocomial Infections. Am J Infect Control 1988; 16(3): 128-140. 10. The European Committee on Antimicrobial Susceptibility Testing. EUCAST Disk Diffusion Test Manual. v 1.0, 2014. Available at: http:// www.eucast. 11. Merlino J, Watson J, Rose B, Beard-Pegler M, Gottlieb T, Bradbury R, et al. Detection and expression of methicillin/oxacillin resistance in multidrug-resistant and non-multidrug-resistant Staphylococcus aureus in Central Sydney, Australia. J Antimicrob Chemother. 2002; 49(5): 793–801. 12. Milheiriço C, Oliveira DC, de Lencastre H. Update to